The Gabrin sign's potential for identifying high‐risk patients for COVID‐19 with androgenic alopecia
Journal of the European Academy of Dermatology and Venereology · 2024
DOI: 10.1111/jdv.19514 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2024. Verfasst von Alpana Mohta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Leprology, Sardar Patel Medical College, Bikaner, Rajasthan, India. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit nennt 8 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology, Venereology and Leprology, Sardar Patel Medical College, Bikaner, Rajasthan, India.
- Department of Preventive and Social Medicine, Sardar Patel Medical College, Bikaner, Rajasthan, India.
- Department of Dermatology, Venereology and Leprosy, Government Medical College, Kota, Rajasthan, India.
ORCID-Profile: Alpana Mohta
Zitieren
APA
Mohta, A., Pareek, S., Prasad, V., Mohta, A., & Nyati, A. (2024). The Gabrin sign's potential for identifying high‐risk patients for COVID‐19 with androgenic alopecia. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19514
Vancouver
Mohta A, Pareek S, Prasad V, Mohta A, Nyati A. The Gabrin sign's potential for identifying high‐risk patients for COVID‐19 with androgenic alopecia. Journal of the European Academy of Dermatology and Venereology. 2024. doi:10.1111/jdv.19514
BibTeX
@article{Mohta2024,
author = {Mohta, Alpana and Pareek, Sumiti and Prasad, Vijeta and Mohta, Achala and Nyati, Asha},
title = {The Gabrin sign's potential for identifying high‐risk patients for COVID‐19 with androgenic alopecia},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2024},
doi = {10.1111/jdv.19514}
}
EUVIMED